Circular RNA CCDC66 Improves Murine Double Minute 4 (MDM4) Expression through Targeting miR-370 in Colorectal Cancer

Yang Mo, Qin Lu, Qi Zhang, Jie Chen, Youming Deng, Ke Zhang, Ran Tao, Weidong Liu, Yiming WangComput. Math. Methods Medicine 2022 · DOI

TL;DR

This study identifies circular RNA CCDC66 (circCCDC66) as a novel oncogenic factor in colorectal cancer (CRC). They demonstrate that circCCDC66 promotes CRC cell proliferation, migration, and invasion by acting as a sponge for miR-370, thereby upregulating the expression of MDM4, a known oncogene.

What Problem Does This Paper Address?

Colorectal cancer (CRC) remains a significant global health challenge, and while circular RNAs (circRNAs) have emerged as crucial regulators in various cancers, their specific roles and mechanisms in CRC are not fully understood. This paper aims to elucidate the function of circCCDC66 in CRC and uncover the underlying molecular mechanisms driving its oncogenic activity.

Methods

The researchers employed a multi-pronged approach to investigate circCCDC66's role in CRC:

  • Expression Analysis: Quantitative Real-Time PCR (qRT-PCR) was used to measure the expression levels of circCCDC66 in CRC tissues and cell lines compared to normal counterparts.
  • Functional Assays:
    • Cell Proliferation: CCK-8 assays and colony formation assays were performed to assess the impact of circCCDC66 overexpression and knockdown on CRC cell proliferation.
  • Cell Migration and Invasion: Transwell assays were utilized to evaluate the effects of circCCDC66 manipulation on the migratory and invasive capabilities of CRC cells.
  • Mechanism Elucidation:
    • Subcellular Localization: Cell fractionation was used to determine the cellular compartment where circCCDC66 resides, which is crucial for its function as a microRNA sponge.
  • miRNA-circRNA Interaction: Dual-luciferase reporter assays were employed to confirm the direct binding between circCCDC66 and miR-370, and between miR-370 and its target gene, MDM4. This involved using wild-type and mutated binding site constructs.
  • Gene Expression Analysis: qRT-PCR was used to assess the expression levels of miR-370 and MDM4 following circCCDC66 manipulation.
  • Rescue Experiments: Transfection with MDM4 siRNA or miR-370 mimics was performed in circCCDC66-overexpressing cells to confirm the miR-370/MDM4 axis as the functional pathway.

Datasets

The study utilized human colorectal cancer (CRC) tissues and matched normal tissues (n=34) obtained from patients undergoing colorectal ectomy. Additionally, several human CRC cell lines (SW620, SW480, HCT-116, and RKO) and one normal colon cell line (NCM460) were used for in vitro experiments. No novel benchmark datasets were introduced.

Key Insights and Ideas

  • circCCDC66 as an Oncogene in CRC: The study firmly establishes circCCDC66 as an upregulated molecule in CRC tissues and cell lines, and its overexpression promotes key hallmarks of cancer, including proliferation, migration, and invasion.
  • The miR-370 Sponge Mechanism: A critical finding is that circCCDC66 acts as a molecular sponge for miR-370. This interaction sequesters miR-370, preventing it from performing its normal regulatory functions.
  • MDM4 as a Downstream Target: The research demonstrates that miR-370 directly targets and regulates the expression of MDM4. By sponging miR-370, circCCDC66 leads to the upregulation of MDM4.
  • MDM4's Oncogenic Role: The study reinforces the known oncogenic role of MDM4 in cancer, showing that its upregulation by circCCDC66 contributes to CRC progression.
  • Therapeutic Potential: The identification of the circCCDC66/miR-370/MDM4 axis provides a potential therapeutic target for CRC, suggesting that modulating this pathway could inhibit tumor growth and metastasis.

Key Results

  • Upregulation of circCCDC66: circCCDC66 expression was significantly higher in CRC tissues compared to normal tissues and in CRC cell lines compared to normal cells.
  • Promotes CRC Cell Growth: Overexpression of circCCDC66 enhanced proliferation, migration, and invasion of HCT-116 and RKO cells, while knockdown of circCCDC66 significantly inhibited these processes.
  • Direct Interaction with miR-370: Dual-luciferase reporter assays confirmed a direct binding site between circCCDC66 and miR-370. Knockdown of circCCDC66 led to increased miR-370 expression.
  • miR-370 Targets MDM4: Dual-luciferase reporter assays also confirmed that miR-370 directly targets MDM4.
  • circCCDC66 Upregulates MDM4: There was a positive correlation between circCCDC66 and MDM4 expression. Knockdown of circCCDC66 reduced MDM4 expression.
  • miR-370/MDM4 Axis Drives Progression: Rescue experiments showed that inhibiting MDM4 (via siRNA) or overexpressing miR-370 could counteract the pro-tumorigenic effects of circCCDC66 overexpression, confirming the miR-370/MDM4 axis.
  • MDM4 Expression in Tumors: MDM4 expression was found to be higher in CRC tumors than in normal tissues.

Limitations and Future Work

The authors acknowledge that the study was primarily conducted in vitro. While they demonstrated the functional role of circCCDC66 and its mechanism in cell lines and patient tissues, further validation in animal models and clinical studies would be beneficial to confirm these findings and their therapeutic implications. Future research could focus on developing targeted therapies against circCCDC66 or exploring the potential of miR-370 as a therapeutic agent to restore its tumor-suppressive function in CRC. Investigating the upstream regulators of circCCDC66 and its role in other cancer types could also be valuable avenues for future work.

Summary updated

BibTeX
@article{mo2022circular,
  author = {Yang Mo and Qin Lu and Qi Zhang and Jie Chen and Youming Deng and Ke Zhang and Ran Tao and Weidong Liu and Yiming Wang},
  title = {{Circular RNA CCDC66 Improves Murine Double Minute 4 (MDM4) Expression through Targeting miR-370 in Colorectal Cancer}},
  journal = {Comput. Math. Methods Medicine},
  year = {2022},
  doi = {10.1155/2022/7723995},
}
Figure